SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-026125
Filing Date
2023-07-31
Accepted
2023-07-31 18:34:37
Documents
1
Period of Report
2023-07-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8790
  Complete submission text file 0001493152-23-026125.txt   10329
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Issuer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACACIA RESEARCH CORPORATION 500 NEWPORT CENTER DRIVE, 7TH FLOOR NEWPORT BEACH CA 92660
Business Address
KUMAR AMIT (Reporting) CIK: 0001191905 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37492 | Film No.: 231128927